Background/Aims: Temporary loop ileostomy is increasingly used in colorectal surgery but necessitates secondary closure. We evaluated postoperative complications, particularly nausea and vomiting, in patients with early, intermediate, or late elective ileostomy closure. Methods: We included all patients undergoing ileostomy closure from 2001 to 2008. Time from ileostomy construction to closure was classified as early (EC, <12 weeks), intermediate (IC, 12–18 weeks), and late (LC, >18 weeks). Using multivariable logistic regression, we compared the frequency of postoperative complications between the groups. Results: We included 134 patients (87 males; median age 71 years, range 29–91). Carcinoma of the rectum (n = 67, 50%) was the main reason for ileostomy construction. The median time to ileostomy closure was 103 days (range 8–461). Among patients with EC, IC, and LC, postoperative nausea occurred in 50.0, 73.1, and 78.6%, respectively (p = 0.006), and postoperative vomiting in 22.5, 57.7, and 59.5%, respectively (p = 0.001). Adjusting for important covariates, the odds ratio for postoperative nausea was 2.0 (95% CI 0.76–5.1) for IC and 4.1 (95% CI 1.2–14.3) for LC compared to EC (p = 0.069). For postoperative vomiting, adjusted odds ratios were 3.8 (95% CI 1.4–10.4) for IC and 4.6 (95% CI 1.4–15.5) for LC (p = 0.012). Other complications did not differ between the groups. Conclusions: These findings suggest that early ileostomy closure might reduce postoperative nausea and vomiting.

Keywords:
Ileostomy closure, Postoperative nausea and vomiting, Morbidity, Loop ileostomy, Early closure
1.
Gastinger I, Marusch F, Steinert R, Wolff S, Koeckerling F, Lippert H: Protective defunctioning stoma in low anterior resection for rectal carcinoma. Br J Surg 2005;92:1137–1142.
2.
Ulrich AB, Seiler C, Rahbari N, Weitz J, Büchler MW: Diverting stoma after low anterior resection: more arguments in favor. Dis Colon Rectum 2009;52:412–418.
3.
Chude GG, Rayate NV, Patris V, Koshariya M, Jagad R, Kawamoto J, Lygidakis NJ: Defunctioning loop ileostomy with low anterior resection for distal rectal cancer: should we make an ileostomy as a routine procedure? A prospective randomized study. Hepatogastroenterology 2008;55:1562–1567.
4.
Hüser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, Friess H: Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg 2008;248:52–60.
5.
Camilleri-Brennan J, Steele RJ: Prospective analysis of quality of life after reversal of a defunctioning loop ileostomy. Colorectal Dis 2002;4:167–171.
6.
Neuman HB, Patil S, Fuzesi S, Wong WD, Weiser MR, Guillem JG, Paty PB, Nash GM, Temple LK: Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment. Ann Surg Oncol 2011;18:1397–1403.
7.
Cakmak A, Aylaz G, Kuzu MA: Permanent stoma not only affects patients’ quality of life but also that of their spouses. World J Surg 2010;34:2872–2876.
8.
Wong KS, Remzi FH, Gorgun E, Arrigain S, Church JM, Preen M, Fazio VW: Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients. Dis Colon Rectum 2005;48:243–250.
9.
Saha AK, Tapping CR, Foley GT, Baker RP, Sagar PM, Burke DA, Sue-Ling HM, Finan PJ: Morbidity and mortality after closure of loop ileostomy. Colorectal Dis 2009;11:866–871.
10.
Perez RO, Habr-Gama A, Seid VE, Proscurshim I, Sousa AH Jr, Kiss DR, Linhares M, Sapucahy M, Gama-Rodrigues J: Loop ileostomy morbidity: timing of closure matters. Dis Colon Rectum 2006;49:1539–1545.
11.
Chand M, Nash GF, Talbot RW: Timely closure of loop ileostomy following anterior resection for rectal cancer. Eur J Cancer Care 2008;17:611–615.
12.
Feo CV, Sortini D, Ragazzi R, De Palma M, Liboni A: Randomized clinical trial of the effect of preoperative dexamethasone on nausea and vomiting after laparoscopic cholecystectomy. Br J Surg 2006;93:295–299.
13.
Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramer MR, Watcha M: Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62–71, table of contents.
14.
Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N: A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441–2451.
15.
Williams L, Armstrong M, Finan P, Sagar P, Burke D: The effect of faecal diversion on human ileum. Gut 2007;56:796–801.
16.
Carlsen E, Bergan AB: Loop ileostomy: Technical aspects and complications. Eur J Surg 1999;165:140–143, discussion 144.
17.
Thalheimer A, Bueter M, Kortuem M, Thiede A, Meyer D: Morbidity of temporary loop ileostomy in patients with colorectal cancer. Dis Colon Rectum 2006;49:1011–1017.
18.
Garcia-Botello SA, Garcia-Armengol J, Garcia-Granero E, Espi A, Juan C, Lopez-Mozos F, Lledo S: A prospective audit of the complications of loop ileostomy construction and takedown. Dig Surg 2004;21:440–446.
19.
Phang PT, Hain JM, Perez-Ramirez JJ, Madoff RD, Gemlo BT: Techniques and complications of ileostomy takedown. Am J Surg 1999;177:463–466.
20.
O’Toole GC, Hyland JM, Grant DC, Barry MK: Defunctioning loop ileostomy: a prospective audit. J Am Coll Surg 1999;188:6–9.
21.
Kaiser AM, Israelit S, Klaristenfeld D, Selvindoss P, Vukasin P, Ault G, Beart RW: Morbidity of ostomy takedown. J Gastrointest Surg 2008;12:437–441.
22.
Bakx R, Busch OR, van Geldere D, Bemelman WA, Slors JF, van Lanschot JJ: Feasibility of early closure of loop ileostomies: a pilot study. Dis Colon Rectum 2003;46:1680–1684.
23.
Mansfield SD, Jensen C, Phair AS, Kelly OT, Kelly SB: Complications of loop ileostomy closure: a retrospective cohort analysis of 123 patients. World J Surg 2008;32:2101–2106.
24.
Hallböök O, Matthiessen P, Leinsköld T, Nyström PO, Sjödahl R: Safety of the temporary loop ileostomy. Colorectal Dis 2002;4:361–364.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.